Market Update After Hours November 12
Summary of the US Stock Markets: Dow is at 12,815.10 mostly flat for the day -0.31 (0.00%), NASDAQ is at 2,904.26, again flat with a change of -0.61 (-0.02%), and S&P stood at 1,380.03...
Tagged: OXGN
OXiGENE – OXGN – In-Licenses Rights to Promising Program for Neuroendocrine Tumors
OXiGENE, Inc. (Nasdaq:OXGN), a clinical-stage biopharmaceutical company developing novel therapeutics to treat cancer, announced the establishment of an exclusive, worldwide licensing agreement with Angiogene Pharmaceuticals Ltd., a U.K.-based drug development company, for data, development...